Heparanase can be used to regulate Sdc-1 levels in the nucleus [2]; however, removal of HS from the nucleus by nuclear heparanase promotes an aggressive tumourigenic phenotype by enhancing HAT activity, which elevates the expression of tumour-promoting genes. Here, HPSE is linked to neoplasm.